Metraipolis › archive › dc_e2efc84029be

Developing and validating a machine learning pharmaceutical therapy recommender system for US-based hospital in-patients with schizophrenia spectrum disorders — Europe PMC PMID:41327062

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41327062
DOI
10.1186/s12888-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-08T02:26:57.082Z
SHA-256 of the archived text
676a41396d72d1629a9505674fbf4c9011ede80c1f1153365fbef75ecc259006
Stable URL of this page
https://metraipolis.com/documento/dc_e2efc84029be

How to cite

Developing and validating a machine learning pharmaceutical therapy recommender system for US-based hospital in-patients with schizophrenia spectrum disorders — Europe PMC PMID:41327062 — Europe PMC (en), https://europepmc.org/article/MED/41327062 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e2efc84029be (Metraipolis archive dc_e2efc84029be, sha256 676a41396d72d1629a9505674fbf4c9011ede80c1f1153365fbef75ecc259006)
BibTeX
@misc{dce2efc84029be,
  title = {Developing and validating a machine learning pharmaceutical therapy recommender system for US-based hospital in-patients with schizophrenia spectrum disorders — Europe PMC PMID:41327062},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41327062},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e2efc84029be; sha256 676a41396d72d1629a9505674fbf4c9011ede80c1f1153365fbef75ecc259006},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41327062. Agents can read the archived copy with the MCP tool read_document.